Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-12-6
pubmed:abstractText
The aim of this study was to assess the value of multimodality imaging using a novel repositioning device with external markers for fusion of single-photon emission computed tomography (SPECT) and computed tomography (CT) images. The additional benefit derived from this methodological approach was analysed in comparison with SPECT and diagnostic CT alone in terms of detection rate, reliability and anatomical assignment of abnormal findings with SPECT.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1619-7070
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1440-51
pubmed:meshHeading
pubmed-meshheading:16133384-Adult, pubmed-meshheading:16133384-Aged, pubmed-meshheading:16133384-Aged, 80 and over, pubmed-meshheading:16133384-Female, pubmed-meshheading:16133384-Humans, pubmed-meshheading:16133384-Image Enhancement, pubmed-meshheading:16133384-Image Interpretation, Computer-Assisted, pubmed-meshheading:16133384-Immobilization, pubmed-meshheading:16133384-Male, pubmed-meshheading:16133384-Middle Aged, pubmed-meshheading:16133384-Neuroendocrine Tumors, pubmed-meshheading:16133384-Octreotide, pubmed-meshheading:16133384-Organotechnetium Compounds, pubmed-meshheading:16133384-Radiopharmaceuticals, pubmed-meshheading:16133384-Reproducibility of Results, pubmed-meshheading:16133384-Sensitivity and Specificity, pubmed-meshheading:16133384-Subtraction Technique, pubmed-meshheading:16133384-Tomography, Emission-Computed, Single-Photon, pubmed-meshheading:16133384-Tomography, X-Ray Computed
pubmed:year
2005
pubmed:articleTitle
Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
pubmed:affiliation
Clinical Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. michael.gabriel@uklibk.ac.at
pubmed:publicationType
Journal Article, Clinical Trial